Alterations in the subcellular distribution of NADPH oxidase p47phox in hypothalamic paraventricular neurons following slow-pressor angiotensin II hypertension in female mice with accelerated ovarian failure

Journal of Comparative Neurology

Volumn 524, Issue 11, 2016, Pages 2251-2265

  Van Kempen, Tracey A ^a,b   Narayan, Ankita ^a,b   Waters, Elizabeth M ^c   Marques Lopes, Jose ^a   Iadecola, Costantino ^a,b   Glass, Michael J ^a,b   Pickel, Virginia M ^a,b   Milner, Teresa A ^a,b,c  

^a FEIL FAMILY BRAIN AND MIND RESEARCH INSTITUTE   (United States)

^b Weill Cornell Medical Center   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Arginine vasopressin antibody; Electron microscopy; GraphPad Prism; Menopause; 4 vinylcyclohexene diepoxide; P47phox NADPH oxidase subunit antibody; RRID:AB_2298320; RRID:AB_2313978; RRID:rid_000081

Indexed keywords

ARGIPRESSIN; P47PHOX PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG; ANGIOTENSIN II; NEUTROPHIL CYTOSOLIC FACTOR 1;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DENDRITE; ENZYME LOCALIZATION; FEMALE; HORMONE ACTION; HYPERTENSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; IMMUNOELECTRON MICROSCOPY; MALE; MENOPAUSE; MOUSE; NERVE CELL; NONHUMAN; OVARY INSUFFICIENCY; OXIDATIVE STRESS; POSTMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; ANIMAL; C57BL MOUSE; DISEASE MODEL; ENZYMOLOGY; IMMUNOHISTOCHEMISTRY; METABOLISM; SEXUAL DEVELOPMENT;

ANGIOTENSIN II; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, IMMUNOELECTRON; NADPH OXIDASE; NEURONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; POSTMENOPAUSE; SEX CHARACTERISTICS;

EID: 84952684437     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.23944     Document Type: Article

References (72)

1. Abramson BL, Melvin RG. 2014. Cardiovascular risk in women: focus on hypertension. Can J Cardiol 30:553-559.
2. Arias-Loza PA, Muehlfelder M, Pelzer T. 2013. Estrogen and estrogen receptors in cardiovascular oxidative stress. Pflugers Arch 465:739-746.
3. Babior BM. 1999. NADPH oxidase: an update. Blood 93:1464-1476.
4. Bedard K, Krause KH. 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87:245-313.
5. Benarroch EE. 2005. Paraventricular nucleus, stress response, and cardiovascular disease. Clin Auton Res 15:254-263.
6. Biag J, Huang Y, Gou L, Hintiryan H, Askarinam A, Hahn JD, Toga AW, Dong HW. 2012. Cyto- and chemoarchitecture of the hypothalamic paraventricular nucleus in the C57BL/6J male mouse: a study of immunostaining and multiple fluorescent tract tracing. J Comp Neurol 520:6-33.
7. Braga VA, Medeiros IA, Ribeiro TP, Franca-Silva MS, Botelho-Ono MS, Guimaraes DD. 2011. Angiotensin-II-induced reactive oxygen species along the SFO-PVN-RVLM pathway: implications in neurogenic hypertension. Braz J Med Biol Res 44:871-876.
8. Brandes RP, Weissmann N, Schroder K. 2014. Nox family NADPH oxidases: Molecular mechanisms of activation. Free Radic Biol Med 76:208-226.
9. Butz GM, Davisson RL. 2001. Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genom 5:89-97.
10. Byers SL, Wiles MV, Dunn SL, Taft RA. 2012. Mouse estrous cycle identification tool and images. PLoS One 7:e35538.
11. Campos C, Sartorio CL, Casali KR, Fernandes RO, Llesuy S, da Rosa Araujo AS, Bello-Klein A, Rigatto KV. 2014. Low-dose estrogen is as effective as high-dose treatment in rats with postmenopausal hypertension. J Cardiovasc Pharmacol 63:144-151.
12. Capone C, Faraco G, Anrather J, Zhou P, Iadecola C. 2010. Cyclooxygenase 1-derived prostaglandin E2 and EP1 receptors are required for the cerebrovascular dysfunction induced by angiotensin II. Hypertension 55:911-917.
13. Capone C, Faraco G, Peterson JR, Coleman C, Anrather J, Milner TA, Pickel VM, Davisson RL, Iadecola C. 2012. Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension. J Neurosci 32:4878-4886.
14. Ceravolo GS, Filgueira FP, Costa TJ, Lobato NS, Chignalia AZ, Araujo PX, Tostes RC, Dantas AP, Fortes ZB, Carvalho MH. 2013. Conjugated equine estrogen treatment corrected the exacerbated aorta oxidative stress in ovariectomized spontaneously hypertensive rats. Steroids 78:341-346.
15. Cheng S, Xanthakis V, Sullivan LM, Vasan RS. 2012. Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study. Hypertension 60:1393-1399.
16. Coleman CG, Wang G, Park L, Anrather J, Delagrammatikas GJ, Chan J, Zhou J, Iadecola C, Pickel VM. 2010. Chronic intermittent hypoxia induces NMDA receptor-dependent plasticity and suppresses nitric oxide signaling in the mouse hypothalamic paraventricular nucleus. J Neurosci 30:12103-12112.
17. phox in paraventricular hypothalamic neurons parallels local free radical production in angiotensin II slow-pressor hypertension. J Neurosci 33:4308-4316.
18. Dantas AP, Franco MC, Silva-Antonialli MM, Tostes RC, Fortes ZB, Nigro D, Carvalho MH. 2004. Gender differences in superoxide generation in microvessels of hypertensive rats: role of NAD(P)H-oxidase. Cardiovasc Res 61:22-29.
19. Drouyer E, LeSauter J, Hernandez AL, Silver R. 2010. Specializations of gastrin-releasing peptide cells of the mouse suprachiasmatic nucleus. J Comp Neurol 518:1249-1263.
20. Faraco G, Iadecola C. 2013. Hypertension: a harbinger of stroke and dementia. Hypertension 62:810-817.
21. Ferguson AV, Latchford KJ. 2000. Local circuitry regulates the excitability of rat neurohypophysial neurones. Exp Physiol 85(Spec No):153S-61S.
22. Froemke RC, Poo MM, Dan Y. 2005. Spike-timing-dependent synaptic plasticity depends on dendritic location. Nature 434:221-225.
23. Goldman JM, Murr AS, Cooper RL. 2007. The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Res B Dev Reprod Toxicol 80:84-97.
24. Gomez RE, Cannata MA, Milner TA, Anwar M, Reis DJ, Ruggiero DA. 1993. Vasopressinergic mechanisms in the nucleus reticularis lateralis in blood pressure control. Brain Res 604:90-105.
25. Gonzalez AD, Wang G, Waters EM, Gonzales KL, Speth RC, Van Kempen TA, Marques-Lopes J, Young CN, Butler SD, Davisson RL, Iadecola C, Pickel VM, Pierce JP, Milner TA. 2012. Distribution of angiotensin type 1a receptor-containing cells in the brains of bacterial artificial chromosome transgenic mice. Neuroscience 226:489-509.
26. Haas JR, Christian PJ, Hoyer PB. 2007. Effects of impending ovarian failure induced by 4-vinylcyclohexene diepoxide on fertility in C57BL/6 female mice. Comp Med 57:443-449.
27. Hof PR, Young WG, Bloom FE, Belichenko PV, Celio MR. 2000. Comparative cytoarchitectonic atlas of the C57BL/6 and 129/SV mouse brains, 1st ed. Amsterdam: Elsevier.
28. Holm, S. 1979. A simple sequentially rejective multiple test procedure. Scand J Statist 6:65-70.
29. Jackson SH, Devadas S, Kwon J, Pinto LA, Williams MS. 2004. T cells express a phagocyte-type NADPH oxidase that is activated after T cell receptor stimulation. Nat Immunol 5:818-827.
30. Kawada N, Imai E, Karber A, Welch WJ, Wilcox CS. 2002. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol 13:2860-2868.
31. Kawano H, Masuko S. 2010. Region-specific projections from the subfornical organ to the paraventricular hypothalamic nucleus in the rat. Neuroscience 169:1227-1234.
32. Lassegue B, San MA, Griendling KK. 2012. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 110:1364-1390.
33. Li JM, Shah AM. 2002. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem 277:19952-19960.
34. Lohff JC, Christian PJ, Marion SL, Arrandale A, Hoyer PB. 2005. Characterization of cyclicity and hormonal profile with impending ovarian failure in a novel chemical-induced mouse model of perimenopause. Comp Med 55:523-527.
35. Lopez-Sepulveda R, Jimenez R, Romero M, Zarzuelo MJ, Sanchez M, Gomez-Guzman M, Vargas F, O'Valle F, Zarzuelo A, Perez-Vizcaino F, Duarte J. 2008. Wine polyphenols improve endothelial function in large vessels of female spontaneously hypertensive rats. Hypertension 51:1088-1095.
36. Lovett-Barron M, Kaifosh P, Kheirbek MA, Danielson N, Zaremba JD, Reardon TR, Turi GF, Hen R, Zemelman BV, Losonczy A. 2014. Dendritic inhibition in the hippocampus supports fear learning. Science 343:857-863.
37. Maric-Bilkan C, Gilbert EL, Ryan MJ. 2014. Impact of ovarian function on cardiovascular health in women: focus on hypertension. Int J Womens Health 6:131-139.
38. Marques-Lopes J, Van KT, Waters EM, Pickel VM, Iadecola C, Milner TA. 2014. Slow-pressor angiotensin II hypertension and concomitant dendritic NMDA receptor trafficking in estrogen receptor beta-containing neurons of the mouse hypothalamic paraventricular nucleus are sex and age dependent. J Comp Neurol 522:3075-3090.
39. Marques-Lopes J, Lynch MK, Van Kempen TA, Waters EM, Wang G, Iadecola C, Pickel VM, Milner TA. 2015. Female protection from slow-pressor effects of angiotensin II involves prevention of ROS production independent of NMDA receptor trafficking in hypothalamic neurons expressing angiotensin 1A receptors. Synapse 69:148-165.
40. Martins D, Nelson K, Pan D, Tareen N, Norris K. 2001. The effect of gender on age-related blood pressure changes and the prevalence of isolated systolic hypertension among older adults: data from NHANES III. J Gend Specif Med 4:10-13.
41. Mayer LP, Devine PJ, Dyer CA, Hoyer PB. 2004. The follicle-deplete mouse ovary produces androgen. Biol Reprod 71:130-138.
42. Mayer LP, Dyer CA, Eastgard RL, Hoyer PB, Banka CL. 2005. Atherosclerotic lesion development in a novel ovary-intact mouse model of perimenopause. Arterioscler Thromb Vasc Biol 25:1910-1916.
43. Milner TA, Waters EM, Robinson DC, Pierce JP. 2011. Degenerating processes identified by electron microscpic immunocytochemical methods.In: Manfredi G, Kawamata H, editors. Neurodegeneration, methods and protocols, 1st ed. New York: Springer. p 23-59.
44. Muehlfelder M, Arias-Loza PA, Fritzemeier KH, Pelzer T. 2012. Both estrogen receptor subtypes, ERalpha and ERbeta, prevent aldosterone-induced oxidative stress in VSMC via increased NADPH bioavailability. Biochem Biophys Res Commun 423:850-856.
45. Nayernia Z, Jaquet V, Krause KH. 2014. New insights on NOX enzymes in the central nervous system. Antioxid Redox Signal 20:2815-2837.
46. Peters A, Palay SL, Webster Hd. 1991. The fine structure of the nervous system, 3rd ed. New York: Oxford University Press.
47. Pierce JP, Kurucz O, Milner TA. 1999. The morphometry of a peptidergic transmitter system before and after seizure. I. Dynorphin B-like immunoreactivity in the hippocampal mossy fiber system. Hippocampus 9:255-276.
48. Pierce JP, Kievits J, Graustein B, Speth RC, Iadecola C, Milner TA. 2009. Sex differences in the subcellular distribution of angiotensin type 1 receptors and NADPH oxidase subunits in the dendrites of C1 neurons in the rat rostral ventrolateral medulla. Neuroscience 163:329-338.
49. Reckelhoff JF, Romero JC. 2003. Role of oxidative stress in angiotensin-induced hypertension. Am J Physiol Regul Integr Comp Physiol 284:R893-R912.
50. Sadeghi M, Khalili M, Pourmoghaddas M, Talaei M. 2012. The correlation between blood pressure and hot flashes in menopausal women. ARYA Atheroscler 8:32-35.
51. Sahambi SK, Visser JA, Themmen AP, Mayer LP, Devine PJ. 2008. Correlation of serum anti-Mullerian hormone with accelerated follicle loss following 4-vinylcyclohexene diepoxide-induced follicle loss in mice. Reprod Toxicol 26:116-122.
52. Sankar P, Zachariah B, Vickneshwaran V, Jacob SE, Sridhar MG. 2015. Amelioration of oxidative stress and insulin resistance by soy isoflavones (from Glycine max) in ovariectomized Wistar rats fed with high fat diet: the molecular mechanisms. Exp Gerontol 63:67-75.
53. Sawchenko PE, Swanson LW. 1982. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat. J Comp Neurol 205:260-272.
54. Sesack SR, Miner LH, Omelchenko N. 2006. Pre-embedding immunoelectron microscopy: applications for studies of the nervous system.In: Zaborszky L, Wouterlood FG, Lanciego JL, editors. Neuroanatomical tract-tracing 3: molecules, neurons, systems. New York: Springer. p 6-71.
55. Share L, Crofton JT. 1993. Interactions between the gonadal steroid hormones and vasopressin and oxytocin. Ann N Y Acad Sci 689:438-454.
56. Souabni H, Machillot P, Baciou L. 2014. Contribution of lipid environment to NADPH oxidase activity: influence of sterol. Biochimie 107:33-42.
57. Sumi D, Hayashi T, Matsui-Hirai H, Jacobs AT, Ignarro LJ, Iguchi A. 2003. 17Beta-estradiol inhibits NADPH oxidase activity through the regulation of p47phox mRNA and protein expression in THP-1 cells. Biochim Biophys Acta 1640:113-118.
58. Thurston RC, Christie IC, Matthews KA. 2012. Hot flashes and cardiac vagal control during women's daily lives. Menopause 19:406-412.
59. Van Kempen TA, Milner TA, Waters EM. 2011. Accelerated ovarian failure: a novel, chemically induced animal model of menopause. Brain Res 1379:176-187.
60. Van Kempen TA, Gorecka J, Gonzalez AD, Soeda F, Milner TA, Waters EM. 2014. Characterization of neural estrogen signaling and neurotrophic changes in the accelerated ovarian failure mouse model of menopause. Endocrinology 155:3610-3623.
61. Van Kempen TA, Marques-Lopes J, Glass MJ, Milner TA. 2015. Sex differences in neural regulation of hypertension. In: Girouard H, editor. Arterial hypertension and brain as an end organ. Scarborough, Ontario, Canada: Research Signpost/Transworld Research Network (in press).
62. Veltmar A, Culman J, Qadri F, Rascher W, Unger T. 1992. Involvement of adrenergic and angiotensinergic receptors in the paraventricular nucleus in the angiotensin II-induced vasopressin release. J Pharmacol Exp Ther 263:1253-1260.
63. Wang G, Milner TA, Speth RC, Gore AC, Wu D, Iadecola C, Pierce JP. 2008. Sex differences in angiotensin signaling in bulbospinal neurons in the rat rostral ventrolateral medulla. Am J Physiol Heart Circ Physiol 295:R1149-R1157.
64. Wang G, Coleman CG, Chan J, Faraco G, Marques-Lopes J, Milner TA, Guruju MR, Anrather J, Davisson RL, Iadecola C, Pickel VM. 2013. Angiotensin II slow-pressor hypertension enhances NMDA currents and NOX2-dependent superoxide production in hypothalamic paraventricular neurons. Am J Physiol Regul Integr Comp Physiol 304:R1096-R1106.
65. Wright LE, Christian PJ, Rivera Z, Van Alstine WG, Funk JL, Bouxsein ML, Hoyer PB. 2008. Comparison of skeletal effects of ovariectomy versus chemically induced ovarian failure in mice. J Bone Miner Res 23:1296-1303.
66. Xue B, Pamidimukkala J, Hay M. 2005. Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am J Physiol Heart Circ Physiol 288(5):H2177-H2184.
67. Xue B, Zhao Y, Johnson AK, Hay M. 2008. Central estrogen inhibition of angiotensin II-Induced hypertension in male mice and the role of reactive oxygen species. Am J Physiol Heart Circ Physiol 295: H1025-H1032.
68. Xue B, Johnson AK, Hay M. 2013. Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen. Am J Physiol Regul Integr Comp Physiol 305:R459-R463.
69. Yanes LL, Romero DG, Moulana M, Lima R, Davis DD, Zhang H, Lockhart R, Racusen LC, Reckelhoff JF. 2011. Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome. Gend Med 8:103-115.
70. 2+ regulation. Cell Signal 20:637-644.
71. Zimmerman MA, Sullivan JC. 2013. Hypertension: what's sex got to do with it? Physiology 28:234-244.
72. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. 2004. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res 95:210-216.